NCT03155152 is a NA clinical trial of DECT in Exercise Performance of Fit Athletes, sponsored by Swiss Federal Institute of Technology.

Who is sponsoring NCT03155152?

NCT03155152 is sponsored by Swiss Federal Institute of Technology.

What drugs are being tested in NCT03155152?

Interventions in NCT03155152: DECT, HIIT.

What condition does NCT03155152 study?

NCT03155152 studies Exercise Performance of Fit Athletes.

Is NCT03155152 still recruiting?

NCT03155152 is currently completed. Last updated 18 March 2020.

Last reviewed 2020-03-18 · How we verify

NCT03155152

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Decremental Exercise: a New Training Approach?

Completed NA Last updated 18 March 2020

What this trial tests

NA trial testing DECT in Exercise Performance of Fit Athletes in 55 participants. Completed in 11 December 2019.

Timeline

1 June 2017

Primary endpoint
11 December 2019

11 December 2019

Quick facts

Lead sponsor	Swiss Federal Institute of Technology
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	55
Start date	1 June 2017
Primary completion	11 December 2019
Estimated completion	11 December 2019
Sites	1 location across Switzerland

Drugs / interventions tested

DECT
HIIT

Conditions studied

Exercise Performance of Fit Athletes — all drugs for Exercise Performance of Fit Athletes →

Sponsor

Swiss Federal Institute of Technology

Who can join

Adults 18 to 40, any sex, with Exercise Performance of Fit Athletes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Different types of high-intensity interval training (HIIT) sessions are used by athletes in order to improve their physical performance, but innovative approaches to training are lacking. Therefore, in Part A of this study the physiological response to a standard HIIT and a new decremental exercise training (DECT) will be compared in runners and cyclists. Next, in Part B the training effects of a 4-week block of the HIIT and DECT will be compared.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Circulating Gal-3 and sST2 are associated with acute exercise-induced sustained endothelial activation: Possible relevance for fibrosis development?
Kröpfl JM, Beltrami FG, Gruber HJ, Schmidt-Trucksäss A, et al · · 2023 · cited 4× · PMID 37572028 · DOI 10.1113/ep091277

Verify or expand the search:

Other trials of DECT

Trials testing the same drug.

NCT04680858 — Impact of Digital Communication Assist Tools in Endoscopic Team Communication During COVID-19 · NA · unknown
NCT03162341 — Study of the Correlation Between UltraSonography and Dual-Energy Computed Tomography Assessment of Urate Deposit · NA · completed
NCT03036410 — Evaluation of Different Phone Solutions in CI and Hearing Aid Users and Bimodal Recipients · NA · completed

Other Swiss Federal Institute of Technology trials

Trials by the same sponsor.

NCT07182734 — Feasibility of Unsupervised Therapy After Neurological or Orthopaedical Injury in the Home Setting With a Hand Rehabilit · NA · not yet recruiting
NCT06725784 — Feasibility and Cost of Robot-assisted Upper Limb Rehabilitation with Different Levels of Supervision · NA · recruiting
NCT06851130 — Assessing the Immediate Increase in Serum Ferritin After Oral Iron Doses: an Experimental Study in Iron-deficient Women · NA · recruiting
NCT06149975 — Feasibility of a Motor-cognitive Training Program in Patients With Traumatic Brain Injury · NA · completed
NCT06116669 — Effects of Oral Iron Supplementation Before vs at Time of Vaccination on Immune Response in Iron Deficient Kenyan Women · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03155152 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Swiss Federal Institute of Technology
Last refreshed: 18 March 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03155152.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing